The FDA last week announced that it is looking into the safety of bluebird bio ’s gene therapy Skysona (elivaldogene ...

Rocket Pharmaceuticals' gene therapy treatments for rare diseases are promising. See why I think high cash burn and potential ...

We can already tinker with human DNA to treat diseases. But being able to edit RNA allows for even more precision – and fewer ...

Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and dev ...

A groundbreaking gene therapy treatment at Cincinnati Children's Hospital has given a 3-year-old boy named Sriansh a new ...

Researchers at Children's Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy ...

In the assessment of 12-month price targets, analysts unveil insights for Voyager Therapeutics, presenting an average target ...

With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

After failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells ...

By Daniella Parra Medera Inc. and CADENCE have launched Asia’s first cardiac gene therapy trial for heart failure in ...

Regenxbio has revealed plans to submit a biologics licence application (BLA) for RGX-202, its investigational gene therapy ...